India pharma giants in $4bn merger

Home › India pharma giants in $4bn merger

India's Sun Pharmaceutical agrees to acquire rival Ranbaxy - majority owned by Japan's Daiichi Sankyo - in an all-stock deal worth $4bn (2.4bn).

27.11	Aston Martin issues second profit warning in two months
27.11	Online slots gambling to be limited to 5 per spin
26.11	Black Friday shoppers warned to be wary of deals
26.11	Trump proves he is serious on tariffs - but it's not about trade
26.11	Sports service SPOTV adopts Zixi for affiliate delivery
26.11	EQT to sell Melita to Goldman Sachs Alternatives
26.11	U.S. spending on standalone pay TV increased in Q3 2024
26.11	DIRECTV terminates agreement to acquire EchoStar's DISH
Consumer Goods and Services »

je.st